[go: up one dir, main page]

TW200731970A - Enhanced efficacy benzisoxazole derivative dosage forms and methods - Google Patents

Enhanced efficacy benzisoxazole derivative dosage forms and methods

Info

Publication number
TW200731970A
TW200731970A TW095138307A TW95138307A TW200731970A TW 200731970 A TW200731970 A TW 200731970A TW 095138307 A TW095138307 A TW 095138307A TW 95138307 A TW95138307 A TW 95138307A TW 200731970 A TW200731970 A TW 200731970A
Authority
TW
Taiwan
Prior art keywords
methods
dosage forms
enhanced efficacy
benzisoxazole derivative
derivative dosage
Prior art date
Application number
TW095138307A
Other languages
Chinese (zh)
Inventor
Michelle Kramer
Peter Briscoe
Sandra Boom
An Vermeulen
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38734884&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW200731970(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US11/262,113 external-priority patent/US20060189635A1/en
Application filed by Alza Corp filed Critical Alza Corp
Publication of TW200731970A publication Critical patent/TW200731970A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Disclosed are dosage forms and methods comprising benzisoxazole derivatives. More particularly, disclosed are dosage forms, methods, and new uses of benzisoxazole derivatives that provide enhanced efficacy when used in the treatment of schizophrenia and/or bipolar mainia.
TW095138307A 2005-10-19 2006-10-18 Enhanced efficacy benzisoxazole derivative dosage forms and methods TW200731970A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72862005P 2005-10-19 2005-10-19
US11/262,113 US20060189635A1 (en) 2005-02-04 2005-10-27 Enhanced efficacy benzisoxazole derivative dosage forms and methods

Publications (1)

Publication Number Publication Date
TW200731970A true TW200731970A (en) 2007-09-01

Family

ID=38734884

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095138307A TW200731970A (en) 2005-10-19 2006-10-18 Enhanced efficacy benzisoxazole derivative dosage forms and methods

Country Status (5)

Country Link
AR (1) AR057161A1 (en)
GT (1) GT200600467A (en)
PE (1) PE20071028A1 (en)
TW (1) TW200731970A (en)
UY (1) UY29877A1 (en)

Also Published As

Publication number Publication date
PE20071028A1 (en) 2007-11-30
GT200600467A (en) 2007-09-21
AR057161A1 (en) 2007-11-21
UY29877A1 (en) 2006-12-29

Similar Documents

Publication Publication Date Title
TW200637522A (en) Skin treatment articles and methods
EP2023926A4 (en) Pyridonecarboxamide derivatives useful in treating hyper-proliferative and angiogenesis disorders
MX349787B (en) Oral dosage forms including an antiplatelet agent and an acid inhibitor.
MX2009000285A (en) Substituted piperidines that increase p53 activity and the uses thereof.
IL190796A0 (en) Compositions and their uses for gene therapy of bone conditions
MY165570A (en) Inhibitors of poly (adp-ribose) polymerase
TW200833662A (en) 4,5-ring annulated indole derivatives and methods of use thereof
MX361467B (en) Isoindoline compounds for use in the treatment of cancer.
TNSN08400A1 (en) Organic compounds and their uses
MX2009006704A (en) New compounds.
CL2007002261A1 (en) COMPOUNDS DERIVED FROM IMIDAZO [1,2-B] PIRIDAZINA, QUINASA INHIBITORS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OR PREVENTION OF CANCER.
EP2192901A4 (en) Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases
UA106367C2 (en) Azadispiro[3.0.4.1]decane derivatives and their uses
MX2010006206A (en) 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases.
MX2010002667A (en) Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors.
MX2008015775A (en) Compounds and compositions for treatment of cancer.
MX2010005012A (en) Compositions for the treatment and prevention of eyelid swelling.
EP1686986A4 (en) Carvedilol salts, corresponding compositions, methods of delivery and/or treatment
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
WO2005000192A3 (en) Glycogen synthase kinase-3 inhibitors
PL1919466T3 (en) Formulations for treatment of lipoprotein abnormalities comprising a statin and a methylnicotinamide derivative
WO2007081878A3 (en) Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cells
WO2007047608A3 (en) Fibrin targeted therapeutics
WO2007130501A3 (en) Combination therapy for treatment of cancer
TW200716088A (en) Formulations and methods for treating amyloidosis